Last reviewed · How we verify

Local OPV — Competitive Intelligence Brief

Local OPV (Local OPV) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

phase 3 Live attenuated vaccine Poliovirus (types 1, 2, and/or 3) Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Local OPV (Local OPV) — GlaxoSmithKline. Local OPV is an oral polio vaccine that provides immunization against poliovirus through oral administration of live attenuated virus.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Local OPV TARGET Local OPV GlaxoSmithKline phase 3 Live attenuated vaccine Poliovirus (types 1, 2, and/or 3)
Pentavalent rotavirus vaccine Pentavalent rotavirus vaccine Sanofi Pasteur, a Sanofi Company marketed Live attenuated vaccine
Varicella Virus Vaccine Live Varicella Virus Vaccine Live Sanofi Pasteur, a Sanofi Company marketed Live attenuated vaccine Varicella-zoster virus (VZV)
BCG Solution BCG Solution Alliance for Clinical Trials in Oncology marketed Live attenuated vaccine / Immunotherapy
Bacille Calmette-Guerin Bacille Calmette-Guerin Urological Oncology Council of Northern Tokyo marketed Live attenuated vaccine / Immunotherapeutic agent
live attenuated Japanese encephalitis vaccine live attenuated Japanese encephalitis vaccine Chinese Academy of Medical Sciences marketed Live attenuated vaccine
Measles, mumps, rubella vaccine Measles, mumps, rubella vaccine PATH marketed Live attenuated vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

  1. GlaxoSmithKline · 19 drugs in this class
  2. Merck Sharp & Dohme LLC · 11 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  4. PATH · 5 drugs in this class
  5. Sanofi · 5 drugs in this class
  6. Bandim Health Project · 5 drugs in this class
  7. Centers for Disease Control and Prevention · 3 drugs in this class
  8. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  9. Beijing Center for Disease Control and Prevention · 2 drugs in this class
  10. Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Local OPV — Competitive Intelligence Brief. https://druglandscape.com/ci/local-opv. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: